Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You bet your ass we have a cure !
Yep - I lost my head LOL
I was thinking cancer vaccines LOL
Its that kind of day
CNBC just mentioned that Etrade is seeing a buy on the rumor in the Bio vaccine area.
That was it -- right after they mentioned what a few stocks were doing today.
Makes sense : cannot say who we are - to small
just saying
Don't Make Me Leak
2 million shares in less than 30 minutes woo woo !
Boom! .23 with a 90,500 share trade
followed by 8674 shares , 3724 shares all at .23
Another 7292 shares and 2708 shares all at .23
Just having some fun here -- we have a long road to go !!!!!
Don't Make Me Leak !!!
Zinc? Vit D ?
Just Asking - You people are the experts
OK - Got it
thanks for the info
So what is the explanation from the people that say you can't short this stock??? Just Asking !!!!!!!! There must be a good explanation right?
Date Close High Low Volume Short Volume % of Vol Shorted
May 19 NA NA NA... 2,868,387... 1,750,453... 61.03
May 18 NA NA NA... 4,987,407... 3,547,233... 71.12
May 15 NA NA NA... 1,021,732... 726,153... 71.07
May 14 NA NA NA... 1,165,304... 518,153... 44.47
May 13 NA NA NA... 1,308,288... 707,182... 54.05
May 12 NA NA NA... 1,161,935... 501,926... 43.20
May 11 NA NA NA... 827,468 ... 393,250... 47.52
May 08 NA NA NA... 1,821,441... 822,440... 45.15
May 07 NA NA NA... 1,170,154... 488,104... 41.71
May 06 NA NA NA... 807,225 ... 349,925 ... 43.35
May 05 NA NA NA... 1,470,835... 812,380... 55.23
May 04 NA NA NA... 1,296,152... 658,115 ... 50.77
May 01 NA NA NA... 1,173,984... 526,980 ... 44.89
LOL - CNN Im sure ask all the tough questions
New York gov avoids tough questions from brother’s news network on disastrous nursing home policy
OK back to dcvax
What is your view of CNN and the Dems ??
I Could not say it any nicer
Easy to understand your thoughts on the possible raise but
It will change --- sooner or later
Is this that time ????? --- so close to news
Well this started on a Monday that is different
Continues on Tuesday
Hey - Hold Tight we will find out soon !
Its 11:48 CST and we are looking at 2.185 million shares traded
Let's see where we go from here - Time to go to another video conf ugh
Thank you iLovetech
All I can say is WOW ----
I'm so excited/happy for your father !!!!!
Thanks Again
Good Luck with that!
As soon as a person has the market figured out --- It changes
All depends how much the wolf pack are willing to spend
Most cancer drugs only achieve clinical benefits in a limited percentage of the patients with the type of cancer being targeted (e.g., 25 – 30% of the patients). In contrast, DCVax has achieved clinical benefits (i.e., longer delay in disease progression and longer extension of survival than with standard of care treatment) in over 80% of the patients who have received DCVax in clinical trials to date. Since DCVax is made with biomarkers from the patient’s own tumor, it is automatically tailored to targets that are present on that patient’s cancer.
dang - I can't believe that I picked up more shares
Last week we had 1 day that vol spiked early in the trading day , I believe that day they locked and the news is getting out now
Just my guess
Don't Make Me Leak
Just asking:
Is DCVAX-L (A) and DCVAX- L (B) in the statistics calculations for median survivor or just
DCVAX-L (B) ?????
I think it makes a difference
Does my question throw off every ones Stats?
Just Asking
Don't Make Me Leak
Watching the trades come across today and everyday since working at home.
I can state with no reservations that the trading pattern has changed.
At least today
Maybe not the bid and ask but and thats a big but
We have been trading at the ask all day .... even during lunch time when patterns change. I know some of you people know what I am talking about (Lunch)
So What the heck --- Still nothing to do but watch as we get closer to our news releases. Yes, my guess is multiple releases
Shoot just ignore me but I feel better while I have to listen to all these crappy video conferences from work.
Don't Make Me Leak
Very Interesting Trades this Morning
Starting with the 5k - 15 minutes before the open .
Its happened before but its still interesting .
Tip Toeing here LOL
Any other stock and I would think a news release was coming out soon.
Wow - Our trades are really Green this morning
Don't Make Me Leak
Hope4patients - I Agree - That's why I have stated in the past and will execute as part of my plan to:
Follow the DCVAX !!!
The company that buys the company out or partnerships with us will do extremely well.
Let's say will do GREAT ! ---- Control the Cancer Market for years
Don't Make Me Leak !
Scotty - right now Wall Street does not have to trust her.
At this price many can't move on the stock price.
Now when data comes out the page will flip and the world will be a brighter place when viewing this company.
Reporting to the SEC is like talking to my hand LOL
To each his own: I prefer:
And so, I wanted to just go through with you now where do we stand today and what do we believe will be the timelines to the remaining steps for announcing the data. Based on where we stand today, with the remaining queries, the remaining confirmations to be done with the hospitals, which we are assuming we will be able to do at least some work with during May, we anticipate that we will reach datalock by approximately the end of May.
“Additionally during this time, we’ve been working on making the data collection as comprehensive as we can. For example, in regard to certain genetic analyses, one that folks have asked us a lot about, I mean everybody knows we’ve been gathering the data on MGMT methylation status. Another genetic measure that folks have asked us quite a bit whether we will be including is IDH mutation status. There have been challenges because of a lot of the bio samples that we’ve collected we collected years ago in the trial. However, I’m happy to say that we have identified a method that we believe will enable us to include the IDH mutation status that effort is underway at present it looks like it will be doable even on bio samples from years ago. And it looks like it will be doable in the same timeframe as the anticipated datalock. So, we’re very happy about that and I’m happy to answer that question that a lot of people have had. The IDH mutation status was a completely unknown factor when our trial started and throughout much of the trial period. But in recent years has come to be recognized as very important in Glioblastoma. So we are continuing with the data collection and anticipate that the datalock will be approximately at the end of May.
“The steps that happen after that, there’s been a bit of confusion, folks have asked questions about how does the process work? What will happen at datalock, as soon as we have datalock the independent statisticians, we are not doing any of the calculations or analyses. They’re all being done by independent statisticians. They will gain access to the clinical trial database. Meaning they will have then access to all of the raw data and they will start doing all the calculations that everybody wants to see. They’ll calculate the median survival and the percent of survival at various time points and all of those various calculations. They will also do a lot of statistical calculations, t-values, hazard ratios, confidence intervals, etc. They will develop graphs and tables, all of the work that will take the raw data points and present them in a way that tells us the results. The clinical outcomes from this trial. That work will take several weeks. We anticipate that work will be taking place in June and as soon as the work by the statisticians is done and delivered to the company, that’s when we the company will become unblinded.
“We will not become unblinded at the time of datalock when the statisticians gain access to the database full of raw datapoints. We will become unblinded when the results of the statisticians, all their calculations and arithmetic gets delivered to us. Then as a final step we will, of course, consult with all of our medical experts. The steering committee of the Phase III trial, the Scientific Advisory Board, etc. And gather any questions or comments that those experts may have and make sure that those are addressed in preparing the information for public presentation. And as soon as that process with the medical experts is done, we will be announcing the results.
“I know the process has gone longer than many would like. We believe that having the process go longer and allowing the dataset to mature more has allowed a stronger and fuller and clearer picture of the capabilities of the DCVAX treatment to become visible, to become clear. Similarly, we think that the careful process that we’ve gone through, which was lengthy, last year developing the statistical analysis plan, and now the data collection and confirmation and cross-checking will give us the most solid basis for looking at the results. This is a very important trial. It’s one of the most important trials in the Glioblastoma space. One of the largest and one of the last Phase III ones to read out. So we felt that was very much in the best interests of the patients, the shareholders, and the company. But, I can assure you, management and the board are every bit as anxious and excited to get to the stage of unblinding and see those results. And we’re really happy to be able to give you this timeline today, this guidance, this visibility. Of course, nothing involving the future is certain. Things, we could hit unexpected bumps in the road. As I said, in mid-February we had no idea what would happen just weeks later and hopefully not some kind of change like that will happen, but we think the finish line is in sight now and we’re excited to be able to lay out this guidance for you. If the guidance changes significantly, we will find a way to announce that or update the guidance. And that’s basically what we wanted to convey and we hope that everyone’s as excited as we are. “
End meeting 13:31
I was thinking it would be a good idea to re-post this part of the Stock Holders meeting. I feel its time to get excited as this week brings us to the middle of May and they weather is going to turn this Wednesday in the Chicago Area. Starting Wed 60's moving to the 70's for the rest of the week. Time to get excited about the weather and Our Little Diamond in the Rough.
So Let's Roll::::::::::::::::::::::::::::::::::::
And so, I wanted to just go through with you now where do we stand today and what do we believe will be the timelines to the remaining steps for announcing the data. Based on where we stand today, with the remaining queries, the remaining confirmations to be done with the hospitals, which we are assuming we will be able to do at least some work with during May, we anticipate that we will reach datalock by approximately the end of May.
“Additionally during this time, we’ve been working on making the data collection as comprehensive as we can. For example, in regard to certain genetic analyses, one that folks have asked us a lot about, I mean everybody knows we’ve been gathering the data on MGMT methylation status. Another genetic measure that folks have asked us quite a bit whether we will be including is IDH mutation status. There have been challenges because of a lot of the bio samples that we’ve collected we collected years ago in the trial. However, I’m happy to say that we have identified a method that we believe will enable us to include the IDH mutation status that effort is underway at present it looks like it will be doable even on bio samples from years ago. And it looks like it will be doable in the same timeframe as the anticipated datalock. So, we’re very happy about that and I’m happy to answer that question that a lot of people have had. The IDH mutation status was a completely unknown factor when our trial started and throughout much of the trial period. But in recent years has come to be recognized as very important in Glioblastoma. So we are continuing with the data collection and anticipate that the datalock will be approximately at the end of May.
“The steps that happen after that, there’s been a bit of confusion, folks have asked questions about how does the process work? What will happen at datalock, as soon as we have datalock the independent statisticians, we are not doing any of the calculations or analyses. They’re all being done by independent statisticians. They will gain access to the clinical trial database. Meaning they will have then access to all of the raw data and they will start doing all the calculations that everybody wants to see. They’ll calculate the median survival and the percent of survival at various time points and all of those various calculations. They will also do a lot of statistical calculations, t-values, hazard ratios, confidence intervals, etc. They will develop graphs and tables, all of the work that will take the raw data points and present them in a way that tells us the results. The clinical outcomes from this trial. That work will take several weeks. We anticipate that work will be taking place in June and as soon as the work by the statisticians is done and delivered to the company, that’s when we the company will become unblinded.
“We will not become unblinded at the time of datalock when the statisticians gain access to the database full of raw datapoints. We will become unblinded when the results of the statisticians, all their calculations and arithmetic gets delivered to us. Then as a final step we will, of course, consult with all of our medical experts. The steering committee of the Phase III trial, the Scientific Advisory Board, etc. And gather any questions or comments that those experts may have and make sure that those are addressed in preparing the information for public presentation. And as soon as that process with the medical experts is done, we will be announcing the results.
“I know the process has gone longer than many would like. We believe that having the process go longer and allowing the dataset to mature more has allowed a stronger and fuller and clearer picture of the capabilities of the DCVAX treatment to become visible, to become clear. Similarly, we think that the careful process that we’ve gone through, which was lengthy, last year developing the statistical analysis plan, and now the data collection and confirmation and cross-checking will give us the most solid basis for looking at the results. This is a very important trial. It’s one of the most important trials in the Glioblastoma space. One of the largest and one of the last Phase III ones to read out. So we felt that was very much in the best interests of the patients, the shareholders, and the company. But, I can assure you, management and the board are every bit as anxious and excited to get to the stage of unblinding and see those results. And we’re really happy to be able to give you this timeline today, this guidance, this visibility. Of course, nothing involving the future is certain. Things, we could hit unexpected bumps in the road. As I said, in mid-February we had no idea what would happen just weeks later and hopefully not some kind of change like that will happen, but we think the finish line is in sight now and we’re excited to be able to lay out this guidance for you. If the guidance changes significantly, we will find a way to announce that or update the guidance. And that’s basically what we wanted to convey and we hope that everyone’s as excited as we are. “
End meeting 13:31
I also cleared out my cash in my acct and purchased additional shares.
fyi: Just saying
The interesting item is: My purchase went off at the Bid.
I realize their are multiple market makers but there you go
Second time they did it -
Of course I made a copy heheheheheh
Why ? who knows --- show the family I guess
OK - Scotty -- So what would you like everyone to do.
What are you telling everyone ..... Lets say you are 100% correct
Give us your expert opinion
Either is the last 100 virus listings LOL
Researcher 'on verge of making very significant' coronavirus findings shot to death
TODAY May 5, 2020, 10:03 PM CDT
A medical researcher said to be on the “verge of making very significant” coronavirus findings was found shot to death over the weekend in Pennsylvania, officials said.
Bing Liu, 37, a researcher for the University of Pittsburgh School of Medicine, was found dead Saturday inside a home in Ross Township, north of Pittsburgh, the Allegheny County Medical Examiner said.
https://www.yahoo.com/news/researcher-verge-making-very-significant-030320409.html
Great virus video
Holdthebag
So you made your point - what would you like to do or have me do about it
NOTHING --- There's nothing to do --- I'm not selling because she extending her warrants for nothing
Any suggestions since you brought it up ????
We don't need a short position - waste of time talking about it
All we need is our DATA -- The rest will take care of itself
And Warrants although recent - Who Cares
Again All we need is our data !
We been here so long -- again -- All we need is our data
Complaining about the past is like complaining about an old girl friend
PERIOD
Don't Make Me Leak
What? NO DILUTION ON A FRIDAY NIGHT !!!
You have some time left tonight -- or you will be so disappointed
All you dudes know who you are.
Many years ago there was a person that received DCVAX and talked about that exact subject. She mentioned that she noticed that she did not even get sick during the winter anymore.
It was on another message board dealing with cancer patients.
Can't remember which one ---- I was young when this started out
Now ? I question myself all the time
Don't Make Me Leak
Merck (NYSE:MRK) announced on April 28 that the U.S. Food and Drug Administration (FDA) had granted accelerated approval for a new treatment schedule for its marquee cancer drug, Keytruda. For context, Keytruda posted $11.1 billion in sales last year. Its closest competitor, Opdivo from Bristol Myers Squibb (NYSE:BMY), generated $7.2 billion in 2019 sales. The stakes are high for these blockbuster drugs, which have changed the cancer treatment landscape in recent years.
Come on Merck - we can steal that 7.2 billion market from Bristol Myers
Together !!!!!!!
Duffy Let Roll !!
Don't Make Me Leak
Didn't know we had 600,000 deaths from the virus ??
Anyone know where that number came from ? he he he he
OK - Its been so long maybe I just forgot about the combo thing ....
Its been a long road .....
Temozolomide plus the vaccine OK
Let's Go
For everyone that thinks we will get more dilution and the price will fall - Who Cares - I will be BUYING
I also like to state that if a person survives 3 to 5 years even 2 don't you think they would just go through the process again??
Get the antigens and create another vaccine?
Do you think people will just give up? No way
- I'm talking more than GBM
Especially 5 year survivors ------
5 years is a long time - so its a cure in my view
Im not even addressing the extra revenue - just talking surviving
I don't think the combo is old news ?? Correct me if Im wrong ...
Here, the researchers announced results of their PhaseIII trial where an autologous tumour-lysate-pulsed Dendritic Cell Vaccine ((DCVax ® -L) was added to the standard programme. In this study after surgery patients received either Temozolomide plus the vaccine, or Temozolomide plus a placebo.
When did the combo start ??
Temozolomide plus the vaccine ????
I'll just wait for our experts to respond - Lucky to have them
Hope4 - your one of them
Give Beartrap both days - it doesn't matter because I have the correct day.
Yea baby start the trash talking
Maybe - But if its part of the plan lets GO!
Get it done - and the new stock or whatever it will be will start to move up quicker then what has happen the last 10 years . Exaggeration OK
HEY - I'm following the DCVAX - Where ever it goes I GO.
DCVAX will make someone the King or Queen of Cancer Care!!!!!
Not looking to stop at a few dollars but a few dollars will give me all I ever looked for. And Able to help others